Ubs Group Ag Cara Therapeutics, Inc. Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 51,432 shares of CARA stock, worth $13,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,432

Previous 36,449 41.11%

Holding current value

$13,372

Previous $26,000 76.92%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.52 - $1.05 $7,791 - $15,732	14,983 Added 41.11%	51,432 $46,000
Q4 2023 Feb 09, 2024	BUY	$0.6 - $1.65 $6,879 - $18,918	11,466 Added 45.9%	36,449 $26,000
Q3 2023 Nov 09, 2023	SELL	$1.67 - $3.33 $18,645 - $37,179	-11,165 Reduced 30.89%	24,983 $41,000
Q2 2023 Aug 11, 2023	SELL	$2.83 - $4.94 $7,507 - $13,105	-2,653 Reduced 6.84%	36,148 $102,000
Q1 2023 May 12, 2023	SELL	$4.89 - $12.27 $105,980 - $265,927	-21,673 Reduced 35.84%	38,801 $190,000

Q4 2022 Feb 08, 2023	BUY	$8.88 - $12.77 $400,088 - $575,352	45,055 Added 292.2%	60,474 $649,000
Q3 2022 Nov 10, 2022	BUY	$8.24 - $12.56 $46,251 - $70,499	5,613 Added 57.24%	15,419 $144,000
Q2 2022 Aug 10, 2022	SELL	$7.45 - $13.84 $44,513 - $82,694	-5,975 Reduced 37.86%	9,806 $90,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $212,556 - $270,507	-21,384 Reduced 57.54%	15,781 $192,000
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $291,920 - $441,654	24,347 Added 189.94%	37,165 $452,000
Q3 2021 Nov 15, 2021	SELL	$11.55 - $16.06 $108,084 - $150,289	-9,358 Reduced 42.2%	12,818 $198,000
Q2 2021 Aug 13, 2021	BUY	$12.38 - $29.19 $41,695 - $98,311	3,368 Added 17.91%	22,176 $317,000
Q1 2021 May 12, 2021	SELL	$15.07 - $21.71 $134,379 - $193,588	-8,917 Reduced 32.16%	18,808 $408,000
Q4 2020 Feb 11, 2021	BUY	$12.72 - $16.16 $90,044 - $114,396	7,079 Added 34.29%	27,725 $419,000
Q3 2020 Nov 12, 2020	SELL	$12.34 - $17.92 $157,248 - $228,354	-12,743 Reduced 38.17%	20,646 $262,000
Q2 2020 Jul 31, 2020	SELL	$12.39 - $17.33 $90,298 - $126,301	-7,288 Reduced 17.92%	33,389 $571,000
Q1 2020 May 01, 2020	SELL	$9.12 - $17.78 $389,506 - $759,366	-42,709 Reduced 51.22%	40,677 $538,000
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $448,953 - $724,010	27,868 Added 50.2%	83,386 $1.34 Million
Q3 2019 Nov 14, 2019	SELL	$18.28 - $26.91 $614,738 - $904,956	-33,629 Reduced 37.72%	55,518 $1.02 Million
Q2 2019 Aug 14, 2019	BUY	$17.68 - $21.57 $395,289 - $482,262	22,358 Added 33.48%	89,147 $1.92 Million
Q1 2019 May 14, 2019	SELL	$14.41 - $19.64 $1.97 Million - $2.68 Million	-136,668 Reduced 67.17%	66,789 $1.31 Million
Q4 2018 Feb 14, 2019	BUY	$12.45 - $23.47 $1.73 Million - $3.26 Million	138,904 Added 215.18%	203,457 $2.64 Million
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $830,340 - $1.13 Million	47,259 Added 273.27%	64,553 $1.55 Million
Q2 2018 Aug 14, 2018	SELL	$11.6 - $19.27 $1.87 Million - $3.1 Million	-160,966 Reduced 90.3%	17,294 $332,000
Q1 2018 May 15, 2018	BUY	$11.77 - $16.08 $1.64 Million - $2.24 Million	139,436 Added 359.15%	178,260 $2.21 Million
Q4 2017 Feb 14, 2018	SELL	$11.86 - $14.08 $855,461 - $1.02 Million	-72,130 Reduced 65.01%	38,824 $475,000
Q3 2017 Nov 14, 2017	BUY	$12.6 - $16.34 $1.19 Million - $1.54 Million	94,181 Added 561.5%	110,954 $1.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	6,229 Added 59.08%	16,773 $258,000
Q1 2017 Nov 14, 2017	BUY	N/A	10,544	10,544 $194,000

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account